Abstract:Khadiga SM Salama, 1 Eman M Moazen, 1 Sawsan B Elsawy, 1 Sanaa F Kotb, 1 Eid M Mohammed, 2 Sara A Tahoun, 3 Marwa A A Ramadan, 3 Samar M Abd Elhamid, 3 Rania H M Bahi, 4 Etemad A Mohammad 5 1 Chest Diseases Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 2 Chest Diseases Department Faculty of Medicine for Men's, Al-Azhar University, Cairo, Egypt; 3 Clinical Pathology Department Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 4 Chest Diseases Department Faculty of Medicine, Zagazig University, Zagazig, Egypt; 5 Chest Diseases Department Faculty of Medicine, Benha University, Benha, Egypt Correspondence: Sawsan B Elsawy, Chest Diseases Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt, Email Background and Aim: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has profound effects on disease progression and patients' quality of life. Emerging evidence suggests an association between alterations in the respiratory microbiome flora species and airway inflammation in patients with AECOPD. The present study aimed to describe the inflammatory cells and bacterial microbiome distributions in respiratory tract in Egyptian patients with AECOPD. Subjects and Methods: The present cross-sectional study included 208 patients with AECOPD. Sputum and broncho-alveolar lavage samples from the studied patients were submitted to microbial cultures using appropriate media. Total and differential leukocytic counts and were done via automated cell counter. Results: The present study included 208 AECOPD patients. They comprised 167 males (80.3%) and 41 females (19.7%) with an age of 57.9 ± 4.9 years. AECOPD was categorized as mild, moderate and severe in 30.8%, 43.3% and 26%, respectively. Sputum samples had significantly higher TLC, neutrophil percent and eosinophil percent when compared with BAL samples. In contrast, lymphocyte percent was significantly higher in BAL samples. Sputum specimens had significantly lower frequency of positive growths (70.2% versus 86.5%, p = 0.001). Among the identified organisms, sputum specimens had significantly lower frequency of Strept. pneumoniae (14.4% versus 30.3%, p = 0.001), Klebsiella pneumoniae (19.7% versus 31.7%, p = 0.024), Haemophilus influenzae (12.5% versus 26.9%, p = 0.011), Pseudomonas aeruginosa (2.9% versus 10%, p = 0.019) and Acinetobacter spp . (1.9% versus 7.2%, p = 0.012) growths when compared with BAL samples. Conclusion: The present study could identify a distinctive pattern of inflammatory cell distribution in sputum and BAL samples of AECOPD patients. The most commonly isolated organisms were Klebsiella pneumoniae and Strept. pneumoniae . Keywords: chronic obstructive pulmonary disease, COPD exacerbation, inflammatory cells, bacterial microbiome, sputum culture, bronchoalveolar culture Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity. It is one of the top three causes of death worldwide and 90% of these deaths occur in low- and middle-income countries. 1,2 Airways of almost 50% of stable COPD patients are colonized by potentially pathogenic microorganisms (PPMs). The most commonly isolated microbes are H. influenzae, M. catarrhalis, S. pneumoniae, S. aureus, and P. aeruginosa . 3 Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an acute and sustained worsening of a patient's condition from a stable state. 4 Possible risk factors include air pollution, seasonal change, ethnic background, associated comorbidities, poor exercise capacity and obesity. 5 Management strategy usually includes bronchodilators and corticosteroids as first-line treatments. In patients with severe exacerbations, noninvasive ventilation, magnesium, ketamine, and epinephrine may be considered. Mechanical ventilation may be needed in selected situations. 6 AECOPD has profound effects on disease progression and patients' quality of life. Prevention of early recurrence and identification of causative agents remains one of the top unmet needs in management of AECOPD. 7 Remarkably, newly developed vaccines against the most frequent bacteria identified in AECOPD are assessed by undergoing trials. 8 Emerging evidence suggests an association between alterations in the respiratory microbial flora species and airway inflammation in patients with AECOPD. 9 Identification of respiratory microbiome has been increasingly recognized as a cornerstone in a modern management direction of AEC -Abstract Truncated-

Lung Mycobiota α-Diversity Is Linked to Severity in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD

A Systematic Review of the Pulmonary Microbiome in Patients with Acute Exacerbation COPD Requiring ICU Admission

Characteristics of the Sputum Microbiome in COPD Exacerbations and Correlations Between Clinical Indices

Loss of Airway Bacterial Phylogenetic Diversity in Mild to Moderate COPD Associates with Clinical and Pathobiological Markers of Disease Development

Airway Bacterial and Fungal Microbiome in Chronic Obstructive Pulmonary Disease

Association of Sputum Microbiome with Clinical Outcome of Initial Antibiotic Treatment in Hospitalized Patients with Acute Exacerbations of COPD.

Dynamics of the lung microbiome in intensive care patients with chronic obstructive pulmonary disease and community-acquired pneumonia

Comprehensive analysis of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity-A prospective, observational study

Dynamic microbial changes in exacerbation of chronic obstructive pulmonary disease

A 16S rDNA sequencing-based analysis of airway microecology in patients with an acute exacerbation of chronic obstructive pulmonary disease: A cross-sectional study in Inner Mongolia, China

Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome

Bacterial Species and Inflammatory Cell Variability in Respiratory Tracts of Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A Multicentric Study

Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease

Clinical Factors Associated with Composition of Lung Microbiota and Important Taxa Predicting Clinical Prognosis in Patients with Severe Community-Acquired Pneumonia

Longitudinal multicompartment characterization of host-microbiota interactions in patients with acute respiratory failure

Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations

The Sputum Microbiome Associated with Different Sub-Types of AECOPD in a Chinese Cohort

Lung microbiota composition, respiratory mechanics, and outcomes in COVID-19-related ARDS

Bacterial Infection, Airway and Systemic Inflammation and Clinical Outcomes Before and after Treatment of AECOPD, a Longitudinal and Cross-Sectional Study.

Lung Microbiota is Associated with Bacterial Detection and with Clinical Improvements in Severe Community-Acquired Pneumonia Patients